FDA DEVICE FACTS
Bloomlife MFM-Pro
Bloom Technologies NV
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Bloomlife MFM-Pro is indicated for monitoring of maternal heart rate (MHR) and fetal heart rate (FHR) during the antepartum period for singleton pregnancies 32 weeks gestation or later.
It is to be used by healthcare professionals in hospitals, clinics, physicians' offices, antepartum rooms, and in the patient's home on the order of a physician.
Bloomlife MFM-Pro is not intended for use in critical care situations or in laboring patients or those patients hospitalized for or suspected to have preterm labor.
Bloomlife MFM-Pro is not intended to be used for antepartum monitoring (e.g., non- stress testing).
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。